Comparison of heart failure therapies- n (%)
| Conservative Management (n=113) | Renal replacement therapy (n=38) | p value | |
|---|---|---|---|
| Medications | |||
| ACE inhibitors | 39 (34.5) | 10 (26) | 0.35 |
| Angiotensin-receptor blockers | 15 (13.3) | 4 (10.5) | 0.66 |
| Sacubitril/Valsartan | 13 (11.5) | 1 (2.6) | 0.10 |
| Beta-blockers | 95 (84.1) | 27 (71.1) | 0.78 |
| MRA | 31 (27.4) | 7 (18.4) | 0.27 |
| SGLT2-inhibitors | 1 (0) | 0 | 0.56 |
| Device therapy | |||
| ICD | 4 (3.5) | 4 (10.8) | 0.096 |
| CRT-D | 23 (20.4) | 1 (2.7) | 0.01 |
| CRT-P | 16 (14.2) | 2 (5.4) | 0.143 |
CRT-D/P: cardiac resynchronisation therapy with defibrillator/pacemaker; ICD= implantable cardioverter defibrillator; MRA= mineralocorticoid receptor antagonist; SGLT2-inhibitor= Sodium-glucose 2 transporter inhibitors